about
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetineEnhancement of dorsal hippocampal activity by knockdown of HCN1 channels leads to anxiolytic- and antidepressant-like behaviors.Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerationsAntidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?Pharmacokinetic/pharmacodynamic considerations for epilepsy - depression comorbidities.Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors.
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Epilepsy, depression and antidepressant drugs.
@ast
Epilepsy, depression and antidepressant drugs.
@en
Epilepsy, depression and antidepressant drugs.
@nl
type
label
Epilepsy, depression and antidepressant drugs.
@ast
Epilepsy, depression and antidepressant drugs.
@en
Epilepsy, depression and antidepressant drugs.
@nl
prefLabel
Epilepsy, depression and antidepressant drugs.
@ast
Epilepsy, depression and antidepressant drugs.
@en
Epilepsy, depression and antidepressant drugs.
@nl
P356
P1476
Epilepsy, depression and antidepressant drugs.
@en
P2093
P304
P356
10.1054/JOCN.2000.0896
P577
2001-05-01T00:00:00Z